Pure Global

The Effect of Stellate Ganglion Block on Insomnia Patients - Trial NCT06255730

Access comprehensive clinical trial information for NCT06255730 through Pure Global AI's free database. This phase not specified trial is sponsored by Zeng Changhao and is currently Recruiting. The study focuses on Insomnia. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06255730
Recruiting
procedure
Trial Details
ClinicalTrials.gov • NCT06255730
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
The Effect of Stellate Ganglion Block on Insomnia Patients
The Effect of Stellate Ganglion Block on Insomnia Patients: a Pre - and Post Control Experiments

Study Focus

Insomnia

Stellate Ganglion Block

Interventional

procedure

Sponsor & Location

Zeng Changhao

People's Hospital of Zhengzhou University

Seoul, South Korea

Timeline & Enrollment

N/A

Feb 28, 2024

Jun 01, 2024

50 participants

Primary Outcome

Pittsburgh Sleep Quality Index

Summary

A prospective study was conducted on Insomnia Patients. All the patients were provided with
 Stellate Ganglion Block. The quality of sleep was evaluated to see if Stellate Ganglion Block
 can improve Insomnia.

ICD-10 Classifications

Nonorganic insomnia
Disorders of initiating and maintaining sleep [insomnias]
Sleep disorders
Sleep disorder, unspecified
Other sleep disorders

Data Source

ClinicalTrials.gov

NCT06255730

Non-Device Trial